Older systemic and newer topical glucocorticosteroids and the gastrointestinal tract

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 4, 1996, Pages 487-496

  Thiesen, A ^a   Thomson, A B R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; ANTIINFLAMMATORY AGENT; PREGNANE DERIVATIVE;

COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DRUG ABSORPTION; DRUG EFFICACY; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG TRANSPORT; GASTROINTESTINAL TRACT; HUMAN; INTRAGASTRIC DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; ULCERATIVE COLITIS; COMPARATIVE STUDY; DRUG EFFECT; HEPATITIS; INTESTINE; METABOLISM; TOPICAL DRUG ADMINISTRATION; TRANSPORT AT THE CELLULAR LEVEL;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL TRANSPORT; BUDESONIDE; COLITIS, ULCERATIVE; GLUCOCORTICOIDS; HEPATITIS; HUMANS; INTESTINES; PREGNENEDIONES;

EID: 0030203240     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.41183000.x     Document Type: Review

References (111)

1. Haynes RCJ, Murad F. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical biosynthesis. In: Gilman AG, Goodman LS, eds. Goodman and Gliman's The Pharmacological Basis of Therapeutics, Vol. 64. New York: Macmillan Publishing, 1985: 1459-89.
2. Haynes RCJ, Larner J. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical biosynthesis. In: Gilman AG, Goodman LS, eds. Goodman and Gliman's The Pharmacological Basis of Therapeutics, Vol. 70. New York: Macmillan Publishing, 1975: 1472-506.
3. Crossland J. The adrenocortical steroids. In: Lewi's Pharmacology, Vol. 44. New York: Churchill Livingstone, 1980: 753-68.
4. Bowman WC, Rand MJ. The endocrine system and drugs affecting endocrine function. In: Textbook of Pharmacology, Vol. 19. Oxford: Blackwell Scientific Publications, 1980: 29-43.
5. Baxter JD. Glucocorticoid hormone action. In: Baxter JD, Rousseau GG, eds. Pharmacology of Adrenal Cortical Hormones, Vol. 3. New York: Springer, 1979: 67-121.
6. Cope CL. Steroid chemistry. In: Adrenal Steroids and Disease, Vol. 1. Philadelphia: Lippincot, 1972: 1-11.
7. Girdwood RH, Petrie JC. Endocrine system and metabolic diseases. In: Girdwood RH, Petrie JC, eds. Textbook of Medical Treatment, Vol. 24. New York: Churchill Livingstone, 1987: 497-9.
8. Aviado DM. Adrenal corticosteroids. In: Krantz and Carr's Pharmacologic Principles of Medical Practice, Vol. 50. Baltimore: Williams & Wilkings, 1972: 779-96.
9. Ehrich E, Lambert RE, McGuire JL. Rheumatic disorders. In: Melmon KL, ed. Melmon and Morrelli's Clinical Pharmacology Basic Principles in Therapeutic, Vol. 19. New York: McGraw-Hill, 1992: 475-6.
10. Benet LZ, Legler UF, Frey BM, Frey FJ, Tsang SY. The immunopharmacokinetics of prednisone/prednisolone. In: Benet LZ, Levy G, Ferraolo BL, eds. Pharmacokinetics A Modern View, Vol. 28. New York: Plenum Press, 1984: 389-102.
11. Laurence DR, Bannet PN. Endocrinology I: adrenal corticosteroids, antagonists, corticotropin. In: Clinical Pharmacology, Vol. 33. Edinburgh: Churchill Livingstone, 1992: 549-63.
12. Johanson SA, Anderson KE, Brattsand R, Gruvstad E, Hedner P. Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Eur J Resp Dis 1982; 63 (Suppl. 122): 74-82.
13. Barr WH, Chung M, Shukur M. Intestinal drug metabolism - presystemic and systemic mechanisms and implications. In: Benet LZ, Levy G, Ferraolo BL, eds. Pharmacokinetics A Modern View. Communication, Vol. 7. New York: Plenum Press, 1984: 426-9.
14. Brattsand R. Overview of newer glucocorticosteroid preparations for inflammatory bowel disease. Can J Gastroenterol 1990; 4: 407-14.
15. Pichard L, Fabre I, Daujat M, et al. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes. Mol Pharmacol 1991; 41: 1047-55.
16. Jonsson G, Astrom A, Anderson P. Budesonide is metabolised by cytochrome P450 3A (CYP3A) enzymes in human liver. Drug Metab Dispos 1995; 23: 137-42.
17. Alberts B, Bray D, Lewis J, et al. Steroid hormones, thyroid hormones, retinoids, and vitamin D bind to intracellular receptors that are ligand-activated gene regulatory proteins. In: Wilson J, Hunt T, eds. Molecular Biology of the Cell, Vol. 15. New York: Garland Publishing, 1994: 729-31.
18. Sibley CH, Tomkins GM. Isolation of lymphoma cell variants to killing glucocorticoids. Cell 1974; 2: 213-20.
19. Yamamoto KR, Stampfer MR, Tomkins GM. Receptors from glucocorticoid-sensitive lymphoma cells and two classes of insensitive clones: physical and DNA-binding properties. Proc Natl Acad Sci USA 1974; 71: 3901-5.
20. Henning SJ, Rubin DC, Shulman RJ. Ontogeny of the intestinal mucosa. In: Johnson LR, Alpers DH, Jacobson ED, Christensen J, Walsh JH, eds. Physiology of the Gastrointestinal Tract, Vol. 13. New York: Raven Press, 1987: 584-6.
21. Galand G, L'Horset F, Longis Y, Perret C. Trehalase gene expression during postnatal development of rabbit intestine and kidney: effects of glucocorticoids. Am J Physiol 1995; 269: G833-41.
22. Lippman ME, Thompson EB. Glucocorticoid unresponsive human and mouse leukemia cells containing cytoplasmic glucocorticoid binding protein. Endocrinology 1974; 94 (Suppl.): A202.
23. Madrestma GS, Van Dijk AP, Wilson JH, Zijlstra FJ, Colitis patients not responding to high dose corticosteroids have a low glucocorticoid receptor content of their mononuclear cells. Gastroenterology 1995; 108 (Suppl. 4): A867.
24. Beattie RM, Goulding JA, Walker-Smith JA, Macdonald TT. Lipocortin-I autoantibody concentration in children with inflammatory bowel disease. Aliment Pharmacol Ther 1995; 9: 541-5.
25. Batt RM, Peters TJ. Effects of prednisolone on the small intestinal mucosa of the rat. Clin Sci Mol Med 1976; 50: 511-23.
26. Batt RM, Peters TJ. Absorption of galactose by the rat small intestine in vivo: proximal distal kinetic gradients and a new method to express absorption per enterocyte. Clin Sci Mol Med 1976; 50: 499-509.
27. Scott J, Jounsell K, Feizi T, Peters TJ. Analysis of microvillus membrane from jejunum of prednisolone-treated rats. Cell Biol Int Rep 1980; 4: 814.
28. Batt RM, Scott J. Response of the Small Intestinal Mucosa to Oral Glucocortisoids. Scand J Gastroenterol 1982; 74 (Suppl.): 75-88.
29. Scott J, Batt RM, Maddison YE, Peters TJ. Differential effect of glucocorticoids on structure and function of adult rat jejunum. Am J Physiol 1981; 241: G306-12.
30. Guo W, Swaniker F, Fonkalsrud EW, Vo K, Karamanoukian R. Effect of intraamniotic dexamethasone administration on intestinal absorption in a rabbit gastroschisis model. J Pediatr Surg 1995; 30: 983-7.
31. Park JHY, Mccusker RH, Mohammadpour H, et al. Dexamethasone inhibits mucosal adaptation. Am J Physiol 1994; 266: G497-503.
32. Murphy BEP. Human fetal serum corticol levels related to gestational age: evidence of a midgestational fall and a steep late gestational rise, independent of sex or mode of delivery. Am J Obstet Gynecol 1982; 144: 276-82.
33. Lebenthal E, Sunshine P, Kretchner N. Effect of Carbohydrate and Corticosteroids on activity of α-glucosidases in Intestine of the infant rat. J Clin Invest 1972; 51: 1244-50.
34. Henning SJ, Sims JM. Delineation of glucocorticoid sensitive period of intestinal development in the rat. Endocrinology 1979: 1158-65.
35. Deren JJ, Broitman SA, Zamcheck N. Effect of diet upon intestinal dissacharidases and dissacharide absorption. J Clin Invest 1967; 46: 186.
36. Nanthakumar NN, Henning SJ. Ontogeny of sucrase-isomaltase gene expression in rat intestine: responsiveness to glucocorticosteroid. Am J Physiol 1993; 264: G306-11.
37. Nanthakumar NN, Henning SJ. Distinguishing normal and glucocorticoid-induced maturation of intestine using bromodeoxyuridine. Am J Physiol 1995; 268: G139-45.
38. Wang Z-M, Yasui M, Celsi G. Differential effects of glucocorticoids and mineralocorticoids on the mRNA expression of colon ion transporters in infant rats. Pediatr Res 1995; 38: 164-8.
39. Sellin JH, Field M. Physiologic and pharmacologic effects of glucocorticoids on ion transport across rabbit ileal mucosa in vitro J. Clin Invest 1981; 67: 770-8.
40. Donowitz M, Wicks J, Sharp GW. Drug therapy for diarrheal diseases: a look ahead. Rev Infect Dis 1986; 8 (Suppl. 2): 188-201.
41. Yeh JK, Aloia JF. Effect of glucocorticoids on the passive transport of phosphate in different segments of the intestine in the rat. Bone & Mineral 1987; 2: 11-19.
42. Truelove SC. Treatment of ulcerative colitis with local hydrocortisonc. Br Med J 1956; 2: 1267-72.
43. Truelove SC. Treatment of ulcerative colitis with local hydrocortisone. Br Med J 1957; 1: 1437-43.
44. Truelove SC. Treatment of ulcerative colites with local hydrocortisone hemisuccinate sodium: A report on a controlled therapeutic trial. Br Med J 1958; 2: 1072-7.
45. Watkinson G. Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium: A controlled trial employing restricted sequential analysis. Br Med J 1958; 2: 1077-82.
46. Matts SGF. Intrarectal treatment of 100 cases of ulcerative colitis with prednisolone 21-phosphate enema. Br Med J 1961; 1: 165.
47. MacDougal I. Treatment of ulcerative colitis with rectal steroids. Lancet 1963; i: 826-7.
48. Danielson A, Prytz H. Oral budesonide for treatment of autoimmune chronic active hepatitis. Aliment Pharmacol Ther 1994; 8: 585-90.
49. Tarpila S, Turunent U, Seppala K, et al. Budesonide enema in active haemorrhagic proctitis - a controlled trial against hydrocortisone foam enema. Aliment Pharmacol Ther 1994; 8: 591-5.
50. Nyman-Pantelidis M, Nilsson A, Wagner GZ, Borga O. Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis. Aliment Pharmacol Ther 1994; 8: 617-22.
51. Lofberg R, Danielsson A, Salde L. Oral budesonide in active Crohn's disease. Aliment Pharmacol Ther 1993; 7: 611-6.
52. Hanauer SB, Schulman MI. New therapeutic approaches. Inflammatory bowel disease. Gastroenterol Clin North Am 1995; 24: 523-30.
53. Loeb JN, Borek C, Yeung LL. Suppression of DNA synthesis in hepatoma cells exposed to glucocorticoid hormone in vitro. Proc Natl Acad Sci USA 1973; 70: 3852-6.
54. Delemos RA, Shermeta JW, Knelson JW, Kotas R, Avery ME. Acceleration of appearance of pulmonary surfactant in the fetal lamb by administration of corticosteroids. Am Rev Respir Dis 1970; 102: 459-61.
55. Motoyama EK, Orzalesi MN, Kimkawa Y, et al. Effect of cortisol on the maturation of fetal rabbit lungs. Paediatrics 1971; 48: 547-55.
56. Ballard PL, Baxter JD, Higgins SJ, et al. General presence of glucocorticoid receptors in mammalian tissues. Endocrinology 1974; 94: 998.
57. Sambhi MP, Weil MH, Udhoji VN. Acute pharmacodynamic effects of glucocorticoids: cardiac output and related hemodynamic changes in normal subjects and patients in shock. Circulation 1965; 31: 523-30.
58. Krakoff L, Nicolis G, Amsel B. Pathogenesis of hypertension in Cushing's syndrome. Am J Med 1975; 58: 216-20.
59. Shimidt GB, Meier MA, Sadque MSS. Sudden appearance of cardiac arrhythmias after dexamethasone. J Am Med Ass 1972; 221: 1402-4.
60. David DS, Greico MH, Cushman P, Jr. Adrenal glucocorticosteroids after twenty years a review of their clinically relevant consequences. J Chron Dis 1970; 22: 637-711.
61. Nicoloff DM. Effect of cortisone and corticotropin on gastric secretion and peptic ulceration in the dog. Archs Surg 1969; 98: 640-4.
62. Okabe S, Saziki R, Takagi K. Cortisone acetate and stress on the healing process of chronic gastric ulcer in rats. J Appl Physiol 1971; 30: 793-6.
63. Spencer JA, Kirsner JB. Experience with short and long term courses of local adrenal steroid therapy for ulcerative colitis. Gastroenterology 1962; 6: 669-77.
64. Farmer RG, Schumacher OP. Treatment of ulcerative colitis with hydrocortisone enemas: Relationship of hydrocortisone absorption, adrenal supression and clinical response. Dis Colon Rectum 1970; 13: 355-61.
65. Cann PA, Holdsworth CD. Systemic absorption from hydrocortisone foam enema in ulcerative colitis. Lancet 1987; i: 922-3.
66. Reshef R, Varkel J, Shiller M, Loberant N. Systemic effects of rectally administered corticosteroids. Isr J Med Sci 1992; 28: 98-100.
67. Mygind N, Clark TJH. Topical Steroid Treatment for Asthma and Rhinitis. London: Baillaire Tindall, 1980: 34-47, 66-76.
68. Martin L, Harrison C, Tanner RJN. Metabolism of beclomethasone dipropionate by animals and man. Postgrad Med J 1975; 51 (Suppl 4): 11-20.
69. Jewell DP, Phill D. The new steroids: clinical experience in ulcerative colitis. Mt Sinai J Med 1990; 57: 293-6.
70. Brattsand R, Thalem A, Roempke K, Kallstrom L, Gruvstad E. Development of glucocorticosteroids with a very high ratio between topical and systemic activities. Eur J Respir Dis 1982; 63 (Suppl. 122): 62-73.
71. Clissold SP, Heel RC, Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis. Drugs 1984; 28: 485-518.
72. Bauer K, Bantje TA, Sipss AP, et al. The effect of inhaled fluticasone propionate, (FP), a new potent corticosteroid in severe asthma. Eur Respir J 1988; 2: 201A.
73. Greenberg GR. Budesonide for the treatment of inflammatory bowel disease. Can J Gastroenterol 1994; 8: 369-72.
74. Juniem JL. Pharmacology of tixocortol pivalate, a glucocorticoid belonging to the 21-thiosteroid family. First Meeting 21-thiosteroids. Mediators of Inflammation: The Local Response, 1988: 65-70.
75. Chanoine F, Grenot C, Sellier N, et al. Isolation and identification of major metabolites of tixocortol pivalate in human urine. Drug Metab Dispos 1987; 15: 868-76.
76. Chanoine F, Junien JL. Comparative pharmacokinetic studies of tixocortol pivalate and cortisol in the rat. J Steroid Biochem 1984; 21: 453-9.
77. Chanoine F. Tixocortol pivalate: Pharmacokinetics and metabolism. First Meeting 21-thiosteroids. Mediators of Inflammation: The Local Response, 1988: 71-82.
78. Hanauer SB. Clinical experience with tixocortol pivalate. Can J Gastroenterol 1988; 2: 156-8.
79. Carpani de Kaski M, Peters AM, Lavender JP, Hodgson HJ. Fluticasone propionate in Crohn's disease. Gut 1991; 32: 657-61.
80. Hawthorne AB, Record CO, Holdsworth CD, Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis. Gut 1993; 34: 125-8.
81. Wright JP, Jarnum S, Schaffalitsky de Muckadell O, et al. Oral fluticasone propionate compared with prednisolone in treatment of active Crohn's disease: a randomized double-blind multicentre study. Eur J Gastroenterol Hepatol 1993; 5: 449-503.
82. Axelsson B, Brattsand R, Anderson PH, Ryrfeldt A, Thalen A. Relationship between glucocorticosteroid effects of beclomethasone 17α, 21-dipropionate, beclomethasone 17α-propionate and beclomethasone as studied in human, mouse and rat tissue. Respiration 1984; 46 (Suppl 1): 4.
83. Van der Heide H, Van den Brandt Gradel V, Tygat GNJ et al. Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis. J Clin Gastroenterol 1988; 10: 169-72.
84. Kumana CR, Meghji M, Seaton T, et al. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic-pituitary-adrenal supression. Lancet 1982, i: 579-85.
85. Levine DS, Rubin CE. Topical beclomethasone dipropionate enemas improve distal ulcerative colitis and idiophatic proctitis without systemic toxicity. Gastroenterology 1985; 88: 1473A.
86. Van der Heide H, Mulder CJJ, Wiltnik EHH, et al. Comparison of enemas containing BDP or PF in treatment of distal ulcerative colites. Gastroenterology 1987; 92: A1679.
87. Halpern Z, Sold O, Baratz M, et al. A controlled trial of beclomethasone versus betamethasone enemas in distal ulcerative colitis. J Clin Gastroenterol 1991; 13: 38-41.
88. Danielsson A, Lofberg R, Persson T, et al. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scand J Gastroenterol 1992; 27: 9-12.
89. Hanauer S, Robinson M and the U.S. Budesonide Enema Study Group. Dose ranging study of budesonide enema in active distal ulcerative colitis. Gastroenterology 1995; 108 (Suppl. 4): A832.
90. Matzen P. Budesonide enema in distal ulcerative colitis. A randomized dose-response trial with prednisolone enema as positive control. The Danish Budesonide Study Group. Scand J Gastroenterol 1991; 26: 1225-30.
91. Lofberg R. Ostergaard Thomsen O, Langholz E, et al. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther 1994; 8: 623-9.
92. Bianchi Porro G, Prantera C, Campieri M, et al. Comparative trial of methylprednisolone and budesonide enemas in active distal ulcerative colitis. Eur J Gastroenterol Hepatol 1994; 6: 125-50.
93. Bayless T, Simnsky C and the US Budesonide Enema Study Group. Budesonide enema is an effective alternative to hydrocortisone enema in active distal ulcerative colitis. Gastroenterology 1995; 108 (Suppl. 4): A778.
94. Lamers CBHW, Meijer J, Engels L, et al. Comparative study of the topically acting glucocorticosteroid budesonide and 5-aminosalicylic acid enema therapy of proctitis and proctosigmoiditis. Gastroenterology 1991; 100: A223.
95. Lemann M, Galian A, Rutgeerts P, et al. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Aliment Pharmacol Ther 1995; 9: 557-62.
96. Sadahiro S, Ito Z, Tijima T, Noguchio M, Hosoi K. Pharmaceutical characterization of corticosteroid suppository treatment for ulcerative colitis. Dig Dis Sci 1992 37: 1898-902.
97. Edsbacker S, Andersson P, Lindberg C, et al. Liver metabolism of budesonide in rat, mouse and man. Drug Metab Dispos Biol Fate Chem 1987; 15: 403-11.
98. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994; 331: 836-11.
99. Rutgeerts P, Lofberg R, Malchow H, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994; 331: 842-5.
100. Campieri M, Ferguson A, Doe W and International Budesonide Study Group. Oral budesonide competes favourably with prednisolone in active Crohn's disease. Gastroenterology 1995; 108 (Suppl4): A790.
101. Rutgeerts P. Budesonide enemas for topical therapy of ulcerative colitis. Can J. Gastroenterol 1990; 4: 415-9.
102. Sachar DB. Budesonide for Inflammatory Bowel Disease. Is it a magic bullet? N Engl J Med 1994; 331: 873-4.
103. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide as maintenance treatment for Crohn's disease: A placebo-controlled dose ranging study. Gastroenterology 1996; 110: 45-51.
104. Lofberg R, Rutgeerts P, Malchow H, et al. Budesonide CIR for maintenance of remission in ileocecal Crohn's disease. A European multi-centre placebo trial for 12 months. Gastroenterology 1994; 106: A722.
105. Bayless TM. Maintenance therapy for Crohn's disease. Gastroenterology 1996; 110: 299-302.
106. Lofberg R, Danielsson A, Nilsson A, et al. Oral budesonide is comparable to prednisolone in active ulcerative colitis but causes no suppression of plasma cortisol. Gastroenterology 1994: 1787. (Abstract presented at the World Congress of Gastroenterology, Los Angeles, California, USA, 2-7 October 1994.)
107. McIntyre PB, Macrae F, Berghouse L, English J, Lennard-Jones JE. Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis. Gut 1985; 26: 822-4.
108. Ford GA, Oliver PS, Shepherd NA, Wilkinson SP. An endragitcoated prednisolone preparation for ulcerative colitis: pharmacokinetics and preliminary therapeutic use. Aliment Pharmacol Ther 1992; 6: 31-40.
109. McLeod AD, Tolentino L, Tozer TN. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: steady-state pharmacokinetics in the rat. Biopharm & Drug Disposition 1994; 15: 151-61.
110. Tozer TN, Rigod J, McLeod AD, et al. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig. PharmRes 1991; 8: 445-54.
111. Cui N, Friend DR, Fedorak RN. A budesonide prodrug accelerates treatment of colitis in rats. But 1994; 35: 1439-46.